LANSEN PHARMACEUTICAL HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong
Limited take
no responsibility for
the contents of this announcement, make no
representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
LANSEN PHARMACEUTICAL HOLDINGS LIMITED朗生醫藥控股有限公司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 503) CHANGE OF COMPANY SECRETARY, CHIEF FINANCIAL OFFICER AND AUTHORIZED REPRESENTATIVE
The Board announces that with effect from 16 September 2015:
(1) Mr. Mui Chi Hung resigned as
Company
Secretary,
Chief Financial Officer and
Authorized Representative of the Company; and
(2) Mr. Leung
Tsz Chun
has been
appointed
as Company Secretary and Authorized
Representative of the Company.
The board of directors (the "Board") of Lansen Pharmaceutical Holdings Limited (the
"Company") announces that Mr. Mui Chi Hung ("Mr. Mui") will resign as Company
Secretary, Chief Financial Officer and one of
the authorized representatives (for the
purpose of Rule 3.05 of
the Rules
Governing
the Listing
of Securities (the "Listing
Part XI of the Hong Kong Companies Ordinance) of the Company, with effect from 16
September 2015, as he has to pursue his other career opportunities. Mr. Mui confirmed that he has no disagreement with the Board and there is no other matter in relation to his resignation that needs to be brought to the attention of the shareholders of the Company or the Stock Exchange.
As at the date of this announcement, the Board has identified a suitable candidate to fill the vacancy of Chief Financial Officer and would endeavour to expedite the appointment process, which is expected to be made in mid-September of 2015. Further announcement will be made in relation to such appointment as and where appropriate.
1
The Board is pleased to announce that Mr. Leung Tsz Chun ("Mr. Leung"), the Finance Manager of the Company, has been appointed as Company Secretary and authorized representative (for the purpose of Rule 3.05 of the Listing Rules and Part XI of the Hong Kong Companies Ordinance) of the Company, with effect from 16 September 2015. Mr. Leung, aged 29, has over 7 years of experience in audit, finance and accounting. Prior to joining the Company in 2014, Mr. Leung worked in KPMG, Hong Kong for six years, last position as Audit Manager. Mr. Leung obtained his Bachelor of Science degree in Biochemistry from Hong Kong University of Science and Technology in 2008. Mr. Leung is a member of Hong Kong Institute of Certified Public Accountants.
The Board takes this opportunity to thank Mr. Mui for his valuable contribution during his tenure of services with the Company and wish him all the best in his new career pursuit.
By Order of the Board
Chairman
Hong Kong, 4 September 2015
As at the date of this announcement, the executive Director is Mr. Liu Bang Min; the non- executive Directors are Mr. Stephen Burnau Hunt, Mr. Lee Jin Yi, Ms. Yip Pui Ling, Rebecca, Mr. Tang Jun and Ms. Tao Fang Fang; the independent non-executive Directors are Mr. Chan Kee Huen, Michael, Mr. Tang Chiu Ping, Raymond and Mr. Fritz Heinrich Horlacher.
2
|
distributed by
|
